Children's Ibuprofen Recalled Over Contamination Fears

The FDA announced a recall of 89,592 bottles of Children's Ibuprofen Oral Suspension, USP, 100mg per 5mL, manufactured by Strides Pharma, Inc. for Taro Pharmaceuticals. This medication was distributed nationwide and is intended for children as a pain reliever and fever reducer.

The recall was initiated after the FDA received complaints detailing foreign substances, such as a gel-like mass and black particles, within the medication. The recall has been classified as Class II, indicating that exposure may cause temporary or medically reversible adverse health effects, with a remote probability of serious consequences.

While the exact nature and origin of the contaminants remain unknown, the presence of foreign objects in the liquid medication could pose a choking hazard to children. No injuries or illnesses have been reported to date in connection with this specific recall.

This incident follows a similar recall in December involving other pain, fever, and cold relief products due to concerns of rodent and bird feces contamination at a Minneapolis facility. That recall, initially issued by Gold Star Distribution, affected numerous well-known brands and prompted warnings about potential serious illness from pest adulteration.